The coronavirus disease 2019 (COVID-19) pandemic has rapidly spread all over the world in the past several months. No effective treatment for COVID-19 has been established. High transmissibility and considerable mortality rates have forced many national governments to implement quarantine measures. Many patients with cancer rely on clinical trials to receive their oncologic care, but the routine conduct of clinical trials has substantially changed because of the COVID-19 pandemic. The oncology research community should implement formal policies based on the guidance given from regulatory agencies, with the goal of minimizing the risks of COVID-19 infection while maintaining appropriate oncologic treatments for patients during this pandemic.
Oncology (Williston Park, N.Y.). 2020 Jul 15 [Epub]
Aline Bobato Lara Gongoria, Denis Leonardo Fontes Jardim, Diogo Assed Bastos
Oncology Center, Hospital Sírio-Libanês, Rua Dona Adma Jafet, 91, São Paulo, Brazil.